Parmax Pharma Standalone March 2024 Net Sales at Rs 4.26 crore, down 33.29% Y-o-Y
June 07, 2024 / 12:12 IST
Reported Standalone quarterly numbers for Parmax Pharma Ltd. are:Net Sales at Rs 4.26 crore in March 2024 down 33.29% from Rs. 6.38 crore in March 2023.
Quarterly Net Loss at Rs. 1.45 crore in March 2024 down 938.58% from Rs. 0.17 crore in March 2023.
EBITDA stands negative at Rs. 0.78 crore in March 2024 down 191.76% from Rs. 0.85 crore in March 2023.
|
| Parmax Pharma Ltd. | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'24 | Dec'23 | Mar'23 | | Net Sales/Income from operations | 4.26 | 1.33 | 6.38 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 4.26 | 1.33 | 6.38 | | EXPENDITURE | | Consumption of Raw Materials | 4.77 | 0.60 | -0.95 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -1.50 | 0.03 | 4.55 | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.50 | 0.84 | 0.60 | | Depreciation | 0.41 | 0.45 | 0.47 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 1.30 | 1.02 | 1.35 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -1.21 | -1.61 | 0.36 | | Other Income | 0.01 | 0.01 | 0.01 | | P/L Before Int., Excpt. Items & Tax | -1.19 | -1.60 | 0.38 | | Interest | 0.16 | 0.16 | 0.05 | | P/L Before Exceptional Items & Tax | -1.36 | -1.75 | 0.32 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -1.36 | -1.75 | 0.32 | | Tax | 0.09 | -- | 0.15 | | P/L After Tax from Ordinary Activities | -1.45 | -1.75 | 0.17 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -1.45 | -1.75 | 0.17 | | Equity Share Capital | 3.74 | 3.74 | 3.74 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -3.88 | -4.68 | 0.46 | | Diluted EPS | -3.88 | -4.68 | 0.46 | | EPS After Extra Ordinary | | Basic EPS | -3.88 | -4.68 | 0.46 | | Diluted EPS | -3.88 | -4.68 | 0.46 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
